Estimating the Costs and Benefits of the 1962 FDA Amendments
Author: John Christopher Leadley
Publisher:
Published: 1985
Total Pages: 378
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author: John Christopher Leadley
Publisher:
Published: 1985
Total Pages: 378
ISBN-13:
DOWNLOAD EBOOKAuthor: Sam Peltzman
Publisher:
Published: 1974
Total Pages: 132
ISBN-13:
DOWNLOAD EBOOK"Measure[s] the net benefits produced by the 1962 amendments to the Food, drug, and cosmetic act." Includes bibliographical references.
Author: Patricia M. Danzon
Publisher: OUP USA
Published: 2012-04-24
Total Pages: 618
ISBN-13: 0199742995
DOWNLOAD EBOOKThis volume examines the economics of the biopharmaceutical industry, with eighteen chapters by health economists.
Author:
Publisher:
Published: 1984
Total Pages: 20
ISBN-13:
DOWNLOAD EBOOKAccompanied by supplements.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2020-01-27
Total Pages: 103
ISBN-13: 0309498511
DOWNLOAD EBOOKTo explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2017-09-28
Total Pages: 483
ISBN-13: 0309459575
DOWNLOAD EBOOKDrug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly
Publisher:
Published: 1967
Total Pages: 828
ISBN-13:
DOWNLOAD EBOOKAuthor:
Publisher:
Published: 1977
Total Pages: 818
ISBN-13:
DOWNLOAD EBOOKIncludes annual List of doctoral dissertations in political economy in progress in American universities and colleges; and the Hand book of the American Economic Association.
Author: Institute of Medicine
Publisher: National Academies Press
Published: 1999-04-29
Total Pages: 158
ISBN-13: 0309184134
DOWNLOAD EBOOKThe Institute of Medicine's (IOM's) Food Forum was established in 1993 to allow science and technology leaders in the food industry, top administrators in the federal government, representatives from consumer interest groups, and academicians to discuss and debate food and food safety issues openly and in a neutral setting. The Forum provides a mechanism for these diverse groups to identify possible approaches for addressing food and food safety problems and issues surrounding the often complex interactions among industry, academia, regulatory agencies, and consumers. On May 6-7, 1997, the Forum convened a workshop titled Enhancing the Regulatory Decision-Making Process for Direct Food Ingredient Technologies. Workshop speakers and participants discussed legal aspects of the direct food additive approval process, changes in science and technology, and opportunities for reform. Two background papers, which can be found in Appendix A and B, were shared with the participants prior to the workshop. The first paper provided a description and history of the legal framework of the food ingredient approval process and the second paper focused on changes in science and technology practices with emphasis placed on lessons learned from case studies. This document presents a summary of the workshop.
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
Publisher:
Published: 1976
Total Pages: 574
ISBN-13:
DOWNLOAD EBOOK